LifeVantage (LFVN) Q1 2027 earnings review
LifeVantage loses more buyers, and its operations swing to a loss
LifeVantage, a direct seller of health supplements and skin care, swung to a net loss as its buyer base kept shrinking. Revenue dropped 22% from a year ago to $37 million, even with a boost from the LoveBiome gut-health line bought last October. Chief executive Terrence Moorehead pointed to a new brand and digital strategy, but active accounts fell to 98,000 and another inventory write-down on its MindBody weight-loss product hurt margins.
| Revenue | $37.1M -22% from a year ago |
|---|---|
| Total active accounts | 98,000 -19% from a year ago (-6,000 from last quarter) |
| Profit per share, excluding one-offs | $0.05 $0.18 a year ago |
| Full-year outlook | None no formal outlook issued for a second quarter |
⚖️ Verdict: 🔴 Bearish
The story got worse because the revenue drop pushed core operations into a reported loss while inventory write-downs returned. Lower variable seller commissions and working-capital collections kept cash flow positive, but overhead rose as a share of sales and management still gave no financial outlook.
The question now is whether Moorehead can stop the slide in active accounts before fixed overhead eats up the remaining cash cushion. Either the digital platform and brand push stabilize the buyer base, or continued account losses and weight-loss drug competition shrink earnings further. Next quarter's active account count and the first clean comparison for LoveBiome will tell.
🐂 Bull Case
Lower Working Capital Keeps Cash Flow Positive
LifeVantage sells nutritional supplements and skin care products through independent sellers and online. Even though the company posted a net loss of $0.2 million this quarter, it generated $0.5 million in cash from operations, compared with $2.3 million of cash used a year ago.
The company brought in cash because it collected bills and shrank its stock of unsold goods, which management noted alongside lower accrued expenses. Because LifeVantage carries no debt and holds $13.7 million in cash, this working-capital release gives chief executive Terrence Moorehead time to execute his turnaround without borrowing.
What to watch: operating cash flow in the second quarter. Once collections and inventory reductions level off, cash generation will have to come from operating profit rather than balance-sheet liquidations.
Flexible Seller Commissions Cushion the Revenue Drop
LifeVantage pays commissions and incentives to the independent consultants who sell its products and recruit buyers. When revenue fell 22.0% from a year ago, those payouts dropped faster, falling 2.1 percentage points of revenue to 41.4%.
The company said the drop came from the timing and size of promotions, product mix, and the mix between customers and consultants. Because seller pay scales down automatically when sales shrink, LifeVantage stayed profitable on a basis excluding one-offs, earning $0.9 million in operating income and $1.9 million in Adjusted EBITDA (earnings before interest, taxes, depreciation, amortization, stock pay, and one-offs).
What to watch: commissions and incentives as a share of revenue next quarter. A jump above 43% without a matching rise in active consultants would show that new promotions are costing margin without rebuilding the seller base.
🐻 Bear Case
Active Account Losses Keep Pulling Sales Down
“Despite a challenging quarter, LifeVantage has significant untapped potential, and we now have a clear strategy designed to capture it,” chief executive Terrence Moorehead said. Moorehead wants to build an expanding community of buyers, and the company blamed the broader macro environment and lower weight-loss product sales for the 22.0% revenue drop.
Yet the buyer base shrank for a seventh straight quarter, even with a boost from LoveBiome, the gut-health product line acquired in October 2025. Because the comparison quarter ended in September 2025 before that deal closed, underlying sales from businesses owned a year ago fell by more than 22.0%.
- Total active accounts: 98,000, down 19.0% from a year ago and down 6,000 from last quarter by our math
- Active independent consultants: 40,000, down 16.7% from a year ago and down 3,000 from last quarter by our math
- Active customers: 58,000, down 20.5% from a year ago and down 3,000 from last quarter by our math
- Revenue per active account: $379 by our math, down 3.6% from $393 a year ago
What to watch: total active accounts in the second quarter, when LifeVantage laps the October 2025 LoveBiome purchase. Another drop of 5,000 to 6,000 accounts would show the seller base is still shrinking before new digital tools arrive.
Unsold Weight-Loss Inventory Hits Gross Margin Again
LifeVantage launched its MindBody GLP-1 System, a supplement package aimed at weight management, in October 2024 to drive growth alongside core lines like Protandim and TrueScience. After an initial surge, demand faded as prescription weight-loss drugs grew, and the company recorded $2.5 million in inventory write-downs across fiscal 2026.
The write-downs continued this quarter. LifeVantage took another $1.0 million charge for obsolete MindBody inventory, which together with higher shipping and warehouse costs pushed gross margin down 4.1 percentage points to 75.4% (or down 1.3 percentage points to 78.2% excluding the write-down). Repeated charges show that prior purchasing still weighs on the cost of making and delivering products.
What to watch: inventory obsolescence charges in the second-quarter release and remaining MindBody stock in the quarterly filing. Another write-down would mean demand for the weight-management line is still falling below internal expectations.
Falling Sales Push Operations Into a Loss
Moorehead said his team is “transforming LifeVantage into a more brand-driven, consumer-focused company, supported by a modern digital platform and an expanding community of consumers and brand advocates” while “creating a more focused and efficient operating model”. He also claimed “a clear roadmap and a strong sense of urgency around execution”, yet the release again included no financial outlook for fiscal 2027.
Meanwhile, fixed overhead is catching up with the shrinking revenue base. Selling, general and administrative expense — corporate overhead and marketing — fell $2.1 million in dollars, but rose 3.1 percentage points as a share of revenue to 34.3%. That pushed the company to a reported operating loss of $0.1 million, down from a $2.3 million operating profit a year ago.
What to watch: whether management issues a fiscal 2027 financial outlook or measurable cost targets next quarter. Without a revenue rebound or deeper overhead cuts, digital and brand spending will keep reported operating profit near or below zero.
Americas Concentration and Missing Launch Updates
Several standing risks got either worse readings or no update in the earnings release.
- Heavy US and Americas reliance: Americas generated 78.0% of revenue and fell 22.2% from a year ago to $29.0 million, while Asia/Pacific and Europe fell 21.2% to $8.2 million.
- Shopify e-commerce rollout: the release gave no update on whether the online platform pilot is live; the conference call or quarterly filing will show its status.
- October convention product launch: the release did not mention the new hero product previously planned for October; call remarks will show if it launched.
- Thailand compensation plan: the release gave no timing update on the fiscal 2027 rollout.
👓 Other Themes
Buybacks Pause While Cash Cushion Shrinks
LifeVantage did not repurchase any common stock during the first quarter, leaving $58.5 million unused under its $60 million buyback plan approved in January 2026. Cash and equivalents fell by $1.2 million from June to $13.7 million at the end of September. Pausing buybacks preserves cash while earnings excluding one-offs sit at $0.05 per share, down from $0.18 a year ago.
💲 Other KPIs
Stock of unsold goods fell 12.0% from last quarter and 30.9% from a year ago, by our math. Part of the drop came from the $1.0 million obsolescence write-down on the MindBody GLP-1 System, while the rest helped generate $0.5 million in operating cash flow.
Money owed by customers and payment processors dropped 39.6% from $3.0 million at the end of June, by our math, outpacing the 12.4% sequential drop in revenue. Collecting those balances helped keep operating cash flow positive despite the net loss.
Weighted-average diluted shares fell 3.7% from 12.9 million a year ago, by our math, and slipped slightly from 12.6 million in the fourth quarter. Because the US direct seller posted a GAAP net loss, basic and diluted share counts were identical this quarter.
❓ Key Questions
What is the current quarterly sales rate of LoveBiome?
The October 2025 LoveBiome acquisition helped offset sales declines in the first quarter, which compared against a pre-acquisition period. Investors need the standalone revenue figure to know how fast the original product lines shrank.
How much MindBody GLP-1 inventory remains on the books?
LifeVantage took another $1.0 million obsolescence charge on the MindBody GLP-1 System after recording $2.5 million in charges across fiscal 2026. Knowing the remaining unreserved inventory value shows how much write-down risk is left.
When will management provide a fiscal 2027 financial outlook?
Chief executive Terrence Moorehead said the company has a clear roadmap, but the release again gave no revenue or profit outlook for fiscal 2027. Concrete targets are needed to judge the turnaround timeline.
What is the status of the Shopify e-commerce rollout?
Moorehead highlighted a modern digital platform as part of his strategy, after the company previously planned to finish its Shopify upgrade in fiscal 2027. Management has not yet confirmed whether the new platform is live in any market.